Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 88.00
0.00 (0.00%)
Sep 16, 2026, 3:30 PM JST
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 6.94 billion as of September 15, 2026. Its market cap has decreased by -21.49% in one year.
Market Cap
6.94B
Enterprise Value
5.64B
Revenue
615.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
88.00
ChartMarket Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 6.94B, an increase of 1,377.60%. That is a compound annual growth rate of 20.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 6.94B | -4.61% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kidswell Bio | 8.35B |
| BrightPath Biotherapeutics | 8.06B |
| StemCell Institute | 7.53B |
| ADR Biomedical Holdings | 7.46B |
| SUSMED,Inc. | 7.16B |
| MEDINET | 6.78B |
| Cyfuse Biomedical K.K. | 6.65B |
| CellSource | 6.43B |